|
1
|
Maida M, Orlando E, Cammà C and Cabibbo G:
Staging systems of hepatocellular carcinoma: A review of
literature. World J Gastroenterol. 20:4141–4150. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li CP, Cai MY, Jiang LJ, Mai SJ, Chen JW,
Wang FW, Liao YJ, Chen WH, Jin XH, Pei XQ, et al: CLDN14 is
epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel
prognostic biomarker in hepatocellular carcinoma. Carcinogenesis.
37:557–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raimondo G, Allain JP, Brunetto MR,
Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta
GB, et al: Statements from the Taormina expert meeting on occult
hepatitis B virus infection. J Hepatol. 49:652–657. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kabel AM, Al-Joaid AA, Al-Ghamdi AA,
Al-Joaid AA and Al-Zaidi WS: Hepatocellular carcinoma: A focus on
the new lines of management. J Cancer Res Treat. 4:55–60. 2016.
|
|
5
|
El-Serag HB, Marrero JA, Rudolph L and
Reddy KR: Diagnosis and treatment of hepatocellular carcinoma.
Gastroenterology. 134:1752–1763. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Llovet JM, Villanueva A, Lachenmayer A and
Finn RS: Advances in targeted therapies for hepatocellular
carcinoma in the genomic era. Nat Rev Clin Oncol. 12:408–424. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SU, Kim DY, Ahn SH, Kim HM, Lee JM,
Chon CY, Park YN, Han KH and Park JY: The impact of steatosis on
liver stiffness measurement in patients with chronic hepatitis B.
Hepatogastroenterology. 57:832–838. 2010.PubMed/NCBI
|
|
8
|
Fattovich G, Stroffolini T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk
factors. Gastroenterology. 127 (5 Suppl 1):S35–S50. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wen J, Liu Y, Liu J, Liu L, Song C, Han J,
Zhu L, Wang C, Chen J, Zhai X, et al: Expression quantitative trait
loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection
and hepatocellular carcinoma development. Mol Carcinog.
54:1275–1282. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Papatheodoridis GV, Lampertico P,
Manolakopoulos S and Lok A: Incidence of hepatocellular carcinoma
in chronic hepatitis B patients receiving nucleos(t)ide therapy: A
systematic review. J Hepatol. 53:348–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
You X, Liu F, Zhang T, Lv N, Liu Q, Shan
C, Du Y, Kong G, Wang T, Ye L and Zhang X: Hepatitis B virus X
protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the
proliferation of hepatoma cells. Oncogene. 33:449–460. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kongkavitoon P, Tangkijvanich P, Hirankarn
N and Palaga T: Hepatitis B virus HBx activates Notch signaling via
delta-like 4/Notch1 in hepatocellular carcinoma. PLoS One.
11:e01466962016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Purow B: Notch inhibition as a promising
new approach to cancer therapy. Adv Exp Med Biol. 727:305–319.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braune EB and Lendahl U: Notch-a
goldilocks signaling pathway in disease and cancer therapy. Discov
Med. 21:189–196. 2016.PubMed/NCBI
|
|
15
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lefort K, Ostano P, Mello-Grand M, Calpini
V, Scatolini M, Farsetti A, Dotto GP and Chiorino G: Dual tumor
suppressing and promoting function of Notch1 signaling in human
prostate cancer. Oncotarget. 7:48011–48026. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shao S and Zhao X, Zhang X, Luo M, Zuo X,
Huang S, Wang Y, Gu S and Zhao X: Notch1 signaling regulates the
epithelial-mesenchymal transition and invasion of breast cancer in
a Slug-dependent manner. Mol Cancer. 14:282015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fender AW, Nutter JM, Fitzgerald TL,
Bertrand FE and Sigounas G: Notch-1 promotes stemness and
epithelial to mesenchymal transition in colorectal cancer. J Cell
Biochem. 116:2517–2527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Q, Wang R, Luo J, Wang P, Xiong S, Liu
M and Cheng B: Notch1 promotes hepatitis B virus X protein-induced
hepatocarcinogenesis via Wnt/β-catenin pathway. Int J Oncol.
45:1638–1648. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan R, Chen P, Zhao D, Tong JL, Li J and
Liu F: Cooperation of deregulated Notch signaling and Ras pathway
in human hepatocarcinogenesis. J Mol Histol. 42:473–481. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu
X, Sun J, Yang S, Poon RT and Fan ST: Notch1-Snail1-E-cadherin
pathway in metastatic hepatocellular carcinoma. Int J Cancer.
131:E163–E172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lim SO, Kim HS, Quan X, Ahn SM, Kim H,
Hsieh D, Seong JK and Jung G: Notch1 binds and induces degradation
of Snail in hepatocellular carcinoma. BMC Biol. 9:832011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niloofar M, Paryan M, Khansarinejad B,
Rafiei M and Mondanizadeh M: Bioinformatic prediction of miRNAs
targeting Notch1 and HBx genes in chronic hepatitis B-induced
hepatocellular carcinoma. Majallah-i dānishgāh-i ulūm-i pizishkī-i
Arāk. 19:89–101. 2017.
|
|
26
|
Pathmanathan N and Balleine RL: Ki67 and
proliferation in breast cancer. J Clin Pathol. 66:512–516. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(review). Mol Med Rep. 11:1566–1572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bologna-Molina R, Mosqueda-Taylor A,
Molina-Frechero N, Mori-Estevez AD and Sánchez-Acuña G: Comparison
of the value of PCNA and Ki-67 as markers of cell proliferation in
ameloblastic tumor. Med Oral Patol Oral Cir Bucal. 18:e174–e179.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumor Biol. 36:7615–7622.
2015. View Article : Google Scholar
|
|
30
|
Huang Y, Tai AW, Tong S and Lok AS: HBV
core promoter mutations promote cellular proliferation through
E2F1-mediated upregulation of S-phase kinase-associated protein 2
transcription. J Hepatol. 58:1068–1073. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sanz-Cameno P, Martín-Vílchez S,
Lara-Pezzi E, Borque MJ, Salmerón J, Muñoz de Rueda P, Solís JA,
López-Cabrera M and Moreno-Otero R: Hepatitis B virus promotes
angiopoietin-2 expression in liver tissue: Role of HBV X protein.
Am J Pathol. 169:1215–1222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang TW, Yevsa T, Woller N, Hoenicke L,
Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova
A, et al: Senescence surveillance of pre-malignant hepatocytes
limits liver cancer development. Nature. 479:547–551. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chung TW, Lee YC and Kim CH: Hepatitis B
viral HBx induces matrix metalloproteinase-9 gene expression
through activation of ERK and PI-3K/AKT pathways: Involvement of
invasive potential. FASEB J. 18:1123–1125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang F, Xia X, Wang J, Sun Q, Luo J and
Cheng B: Notch1 signaling contributes to the oncogenic effect of
HBx on human hepatic cells. Biotechnol Lett. 35:29–37. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ye QF, Zhang YC, Peng XQ, Long Z, Ming YZ
and He LY: Silencing Notch-1 induces apoptosis and increases the
chemosensitivity of prostate cancer cells to docetaxel through
Bcl-2 and Bax. Oncol Lett. 3:879–884. 2012.PubMed/NCBI
|
|
36
|
Park IY, Sohn BH, Yu E, Suh DJ, Chung YH,
Lee JH, Surzycki SJ and Lee YI: Aberrant epigenetic modifications
in hepatocarcinogenesis induced by hepatitis B virus X protein.
Gastroenterology. 132:1476–1494. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karimian A, Ahmadi Y and Yousefi B:
Multiple functions of p21 in cell cycle, apoptosis and
transcriptional regulation after DNA damage. DNA Repair (Amst).
42:63–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lv WP, Zhou KL, Gao B, Chen YL, Xiang X,
Su M and Dong JH: Hepatitis B virus X protein induces malignant
transformation tendency of Chang liver cells involving p16(INK4a)
hypermethylation. Beijing Da Xue Xue Bao Yi Xue Ban. 44:932–936.
2012.(In Chinese). PubMed/NCBI
|
|
39
|
Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu
Z, Liu R and Wu Z: Epigenetic repression of miR-132 expression by
the hepatitis B virus × protein in hepatitis B virus-related
hepatocellular carcinoma. Cell Signal. 25:1037–1043. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kunter I, Atabey N and Erdal E: Inhibition
of the PI3K/Akt signalling caused G0/G1 arrest through the
mechanism of Rb/E2F1 on the HCC cell lines. Int Cong Mol Med.
61:2009.
|
|
41
|
Chen J, Li X, Cheng Q, Ning D, Ma J, Zhang
ZP, Chen XP and Jiang L: Effects of cyclin D1 gene silencing on
cell proliferation, cell cycle, and apoptosis of hepatocellular
carcinoma cells. J Cell Biochem. 119:2368–2380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Calvisi D and Eferl R: CDK4/6 inhibition
and sorafenib: A ménage à deux in HCC therapy? Gut. 66:1179–1180.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gao J, Dong Y, Zhang B, Xiong Y, Xu W,
Cheng Y, Dai M, Yu Z, Xu H and Zheng G: Notch1 activation
contributes to tumor cell growth and proliferation in human
hepatocellular carcinoma HepG2 and SMMC7721 cells. Int J Oncol.
41:1773–1781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qi R, An H, Yu Y, Zhang M, Liu S, Xu H,
Guo Z, Cheng T and Cao X: Notch1 signaling inhibits growth of human
hepatocellular carcinoma through induction of cell cycle arrest and
apoptosis. Cancer Res. 63:8323–8329. 2003.PubMed/NCBI
|
|
45
|
Villanueva A, Alsinet C, Yanger K, Hoshida
Y, Zong Y, Toffanin S, Rodriguez-Carunchio L, Solé M, Thung S,
Stanger BZ and Llovet JM: Notch signaling is activated in human
hepatocellular carcinoma and induces tumor formation in mice.
Gastroenterology. 143:1660–1669.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
